InnoventBio
Founded in 2011, Innovent Biologics is dedicated to the research, development, production, and commercialization of innovative drugs for major diseases including oncology, autoimmune diseases, metabolic diseases, and ophthalmology. The company has established more than 30 strategic collaborations with international partners such as Eli Lilly, Roche, Takeda, Sanofi, Incyte, and MD Anderson Cancer Center.[innoventbio.com]
-
About Rituximab [anti-CD20 antibody] Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the […]
-
About Adalimumab [TNF inhibitor] Adalimumab is an anti-TNF drug used for various types of arthritis. Adalimumab is used to treat various autoimmune […]
